Literature DB >> 3477645

Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 A resolution.

M Fujinaga1, A R Sielecki, R J Read, W Ardelt, M Laskowski, M N James.   

Abstract

The molecular structure of the complex between bovine pancreatic alpha-chymotrypsin (EC 3.4.4.5) and the third domain of the Kazal-type ovomucoid from Turkey (OMTKY3) has been determined crystallographically by the molecular replacement method. Restrained-parameter least-squares refinement of the molecular model of the complex has led to a conventional agreement factor R of 0.168 for the 19,466 reflections in the 1.8 A (1 A = 0.1 nm) resolution shell [I greater than or equal to sigma (I)]. The reactive site loop of OMTKY3, from Lys13I to Arg21I (I indicates inhibitor), is highly complementary to the surface of alpha-chymotrypsin in the complex. A total of 13 residues on the inhibitor make 113 contacts of less than 4.0 A with 21 residues of the enzyme. A short contact (2.95 A) from O gamma of Ser195 to the carbonyl-carbon atom of the scissile bond between Leu18I and Glu19I is present; in spite of it, this peptide remains planar and undistorted. Analysis of the interactions of the inhibitor with chymotrypsin explains the enhanced specificity that chymotrypsin has for P'3 arginine residues. There is a water-mediated ion pair between the guanidinium group on this residue and the carboxylate of Asp64. Comparison of the structure of the alpha-chymotrypsin portion of this complex with the several structures of alpha and gamma-chymotrypsin in the uncomplexed form shows a high degree of structural equivalence (root-mean-square deviation of the 234 common alpha-carbon atoms averages 0.38 A). Significant differences occur mainly in two regions Lys36 to Phe39 and Ser75 to Lys79. Among the 21 residues that are in contact with the ovomucoid domain, only Phe39 and Tyr146 change their conformations significantly as a result of forming the complex. Comparison of the structure of the OMTKY3 domain in this complex to that of the same inhibitor bound to a serine proteinase from Streptomyces griseus (SGPB) shows a central core of 44 amino acids (the central alpha-helix and flanking small 3-stranded beta-sheet) that have alpha-carbon atoms fitting to within 1.0 A (root-mean-square deviation of 0.45 A) whereas the residues of the reactive-site loop differ in position by up to 1.9 A (C alpha of Leu18I). The ovomucoid domain has a built-in conformational flexibility that allows it to adapt to the active sites of different enzymes. A comparison of the SGPB and alpha-chymotrypsin molecules is made and the water molecules bound at the inhibitor-enzyme interface in both complexes are analysed for similarities and differences.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3477645     DOI: 10.1016/0022-2836(87)90659-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

1.  Modulation of protein-protein interactions by synthetic receptors: design of molecules that disrupt serine protease-proteinaceous inhibitor interaction.

Authors:  Hyung Soon Park; Qing Lin; Andrew D Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Electrostatics in protein-protein docking.

Authors:  Alexander Heifetz; Ephraim Katchalski-Katzir; Miriam Eisenstein
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

3.  Intermolecular relaxation has little effect on intra-peptide exchange-transferred NOE intensities.

Authors:  Adam P R Zabell; Carol Beth Post
Journal:  J Biomol NMR       Date:  2002-04       Impact factor: 2.835

4.  Protein-protein docking with multiple residue conformations and residue substitutions.

Authors:  David M Lorber; Maria K Udo; Brian K Shoichet
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

5.  Asymmetric mutation rates at enzyme-inhibitor interfaces: implications for the protein-protein docking problem.

Authors:  James R Bradford; David R Westhead
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

6.  Molecular basis for the resistance of an insect chymotrypsin to a potato type II proteinase inhibitor.

Authors:  K M Dunse; Q Kaas; R F Guarino; P A Barton; D J Craik; M A Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

7.  Probing the effect of point mutations at protein-protein interfaces with free energy calculations.

Authors:  Martin Almlöf; Johan Aqvist; Arne O Smalås; Bjørn O Brandsdal
Journal:  Biophys J       Date:  2005-11-04       Impact factor: 4.033

8.  Amino acid sequences of ovomucoid third domain from 25 additional species of birds.

Authors:  M Laskowski; I Apostol; W Ardelt; J Cook; A Giletto; C A Kelly; W Y Lu; S J Park; M A Qasim; H E Whatley
Journal:  J Protein Chem       Date:  1990-12

9.  Assignment of 1H, 13C, and 15N signals of turkey ovomucoid third domain at pH 2.0.

Authors:  S Choe; Z Dzakula; E S Kuloglu; J L Markley
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

10.  Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.

Authors:  T L Bigler; W Lu; S J Park; M Tashiro; M Wieczorek; R Wynn; M Laskowski
Journal:  Protein Sci       Date:  1993-05       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.